India, China Firms License HIV Drug For Developing World
This article was originally published in PharmAsia News
Executive Summary
Aurobindo, Cipla, Emcure, Hetero and Laurus Labs of India, plus Desano of China have sub-licensed Gilead's TAF (tenofovir alafenamide), a retroviral for treating HIV.